TMates vs He & She MD: Flat $199 vs Intro Pricing and Coaching
Quick verdict: TMates is a flat-rate, physician-forward semaglutide program at $199/month with 24/7 U.S. doctor access; He & She MD offers lower introductory semaglutide pricing from $139/month and bundles coaching, messaging, and multiple medication formats.
Sign up for TMates semaglutide
TMates vs He & She MD: core differences at a glance
This comparison of TMates vs He & She MD focuses on the most distinctive differences the sources supply: pricing structure, clinician access and support model, medication options, shipping and terms, and the compounded-medication regulatory note. Each point below contrasts the two providers directly using only the supplied facts.
1. Pricing structure and commitments
TMates: Priced at $199/month flat, the same rate at every dose, with messaging that the model avoids step-up fees as dosage escalates. The TMates source repeatedly states a flat $199/month at every dose and describes program pricing as predictable.
He & She MD: Headline semaglutide injections start at $139/month as a six-month introductory rate that renews higher. The provider lists semaglutide from $139/mo and tirzepatide from $199/mo as promotional six-month prices that renew at the regular six-month price after the first term.
2. Clinician access and coaching
TMates: Emphasizes 24/7 access to U.S.-based doctors, not just messaging support, plus virtual check-in appointments for ongoing medical oversight.
He & She MD: Bundles an app with 1:1 clinician messaging, GLP-1 coaching and progress tracking at no extra cost. The source frames this as built-in coaching and clinician access rather than 24/7 physician availability.
3. Medication formats and offerings
TMates: Focuses on clinically dosed compounded semaglutide formulated in U.S. facilities. The source notes compounded semaglutide and mentions limited public detail on tirzepatide availability.
He & She MD: Sells semaglutide injections, oral semaglutide, and tirzepatide injection formats. Pricing lists semaglutide injections, oral semaglutide, and tirzepatide with promotional and renewal rates.
4. Shipping, fees and cancellation notes
TMates: Promotes free shipping and a cancel-anytime message. The listing states free shipping and same price all doses.
He & She MD: Promotes free expedited shipping with no membership fee and no insurance required, while emphasizing the six-month introductory pricing structure and renewal at higher rates.
5. Regulatory and eligibility notes
Both sources include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. He & She MD also states that medications require consultation and prescription and not all customers will qualify.
| Criteria | TMates | He & She MD |
|---|---|---|
| Starting price | $199/month flat at every dose | Semaglutide from $139/mo intro; tirzepatide from $199/mo intro |
| Pricing structure | Flat monthly fee with no step-up fees | Six-month introductory rates that renew higher |
| Clinician access | 24/7 U.S. doctor access plus virtual check-ins | 1:1 clinician messaging and coaching via app |
| Medication options | Compounded semaglutide formulated in U.S. facilities | Semaglutide injection, oral semaglutide, tirzepatide injection |
| Shipping and fees | Free shipping; cancel anytime messaging | Free expedited shipping; no membership fee; renews at higher price |
| Regulatory note | Compounded meds are not FDA-approved | Compounded meds produced in USP-compliant pharmacies; not FDA-reviewed |
How support and price affect choice
If your priority is predictable month-to-month billing and direct physician availability, TMates’ flat $199/month and 24/7 U.S. doctor access is the explicitly stated model. If you want lower introductory pricing and a coaching app with 1:1 messaging plus multiple medication formats, He & She MD advertises intro semaglutide from $139/month and an app bundled in the plan.
Missing evidence and limits
The sources do not supply comparative effectiveness data, long-term outcomes, or specific renewal dollars beyond He & She MD’s stated renewal structure. Do not infer clinical outcomes or insurance coverage beyond what each source explicitly states.
Patient scenarios: who each provider fits
Choose TMates if you want a consistent flat-rate semaglutide plan, 24/7 U.S. doctor access, and predictable month-to-month billing with free shipping.
Choose He & She MD if you prefer lower introductory semaglutide pricing from $139/month, built-in coaching and 1:1 clinician messaging in an app, or require oral semaglutide or tirzepatide injection options and are prepared for six-month promo terms that renew at higher rates.
Final note: Both providers explicitly state that compounded GLP-1 medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality. The choice between TMates vs He & She MD depends on whether you value a flat physician-access model or promotional pricing plus bundled coaching. TMates vs He & She MD remains a choice between price model and support format based on the supplied facts.